NPI: 1700845286 · LOS ANGELES, CA 90027 · End-Stage Renal Disease (ESRD) Treatment Clinic/Center · NPI assigned 03/22/2006
Authorized official WEY, SAMUEL controls 20+ related entities in our dataset. Read more
| Authorized Official | WEY, SAMUEL (VP, LICENSURE & CERTIFICATION) |
| NPI Enumeration Date | 03/22/2006 |
Other providers sharing the same authorized official: WEY, SAMUEL
| Provider | City | State | Total Paid |
|---|---|---|---|
| DVA HEALTHCARE RENAL CARE INC | NORTH HOLLYWOOD | CA | $16.47M |
| DVA HEALTHCARE RENAL CARE INC | DELANO | CA | $16.43M |
| DVA RENAL HEALTHCARE INC | LOS ANGELES | CA | $15.51M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $14.93M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.67M |
| DVA RENAL HEALTHCARE INC | OAKLAND | CA | $13.42M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $13.25M |
| DVA HEALTHCARE RENAL CARE INC | YUMA | AZ | $12.88M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $12.77M |
| DVA RENAL HEALTHCARE INC | FULLERTON | CA | $12.19M |
| DVA HEALTHCARE RENAL CARE INC | POMONA | CA | $11.96M |
| DVA RENAL HEALTHCARE INC | ANAHEIM | CA | $11.32M |
| DVA RENAL HEALTHCARE INC | ESCONDIDO | CA | $10.94M |
| DVA HEALTHCARE RENAL CARE INC | COSTA MESA | CA | $10.08M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $9.46M |
| DVA RENAL HEALTHCARE INC | VISALIA | CA | $9.22M |
| DVA RENAL HEALTHCARE INC | SAN DIEGO | CA | $8.83M |
| DVA HEALTHCARE RENAL CARE INC | BAKERSFIELD | CA | $8.56M |
| DVA HEALTHCARE RENAL CARE INC | INGLEWOOD | CA | $7.78M |
| DVA RENAL HEALTHCARE INC | PALM SPRINGS | CA | $7.48M |
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 12,034 | $2.43M |
| 2019 | 9,016 | $888K |
| 2020 | 10,586 | $1.51M |
| 2021 | 16,000 | $1.70M |
| 2022 | 12,627 | $2.13M |
| 2023 | 14,308 | $2.53M |
| 2024 | 12,730 | $2.07M |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 90999 | Unlisted dialysis procedure, inpatient or outpatient | 46,833 | 4,716 | $8.70M |
| 0821 | 4,078 | 1,185 | $4.28M | |
| Q4081 | Injection, epoetin alfa, 100 units (for esrd on dialysis) | 12,182 | 1,739 | $103K |
| J1270 | Injection, doxercalciferol, 1 mcg | 5,638 | 878 | $56K |
| J1756 | Injection, iron sucrose, 1 mg | 6,048 | 2,141 | $55K |
| A4657 | Syringe, with or without needle, each | 5,338 | 1,651 | $25K |
| J0887 | Injection, epoetin beta, 1 microgram, (for esrd on dialysis) | 1,011 | 568 | $8K |
| 83970 | 796 | 777 | $4K | |
| 90662 | 51 | 50 | $4K | |
| 85048 | 1,006 | 958 | $3K | |
| 90677 | 21 | 21 | $3K | |
| 83540 | 426 | 409 | $2K | |
| 90674 | 155 | 152 | $2K | |
| 0250 | 1,842 | 117 | $2K | |
| 85041 | 985 | 937 | $2K | |
| 82728 | 354 | 340 | $748.08 | |
| 83550 | 387 | 371 | $373.07 | |
| 90661 | 15 | 15 | $172.10 | |
| G0008 | Administration of influenza virus vaccine | 43 | 42 | $102.50 |
| 0302 | 69 | 53 | $0.29 | |
| G0499 | Hepatitis b screening in non-pregnant, high risk individual includes hepatitis b surface antigen (hbsag), antibodies to hbsag (anti-hbs) and antibodies to hepatitis b core antigen (anti-hbc), and is followed by a neutralizing confirmatory test, when performed, only for an initially reactive hbsag result | 23 | 19 | $0.00 |